SCYNEXIS, Inc. (SCYX) Financials

SCYX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 77.6 million 36.3 million
Dec. 31, 2025 59.0 million 9.7 million
Sept. 30, 2025 51.1 million 14.6 million
June 30, 2025 60.7 million 16.2 million

SCYX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -8.1 million 580000
Dec. 31, 2025 18.4 million 687000
Sept. 30, 2025 -8.7 million 526000
June 30, 2025 -7.5 million 820000

SCYX Net Income

No data available :(

SCYX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 59.3 million 1.6 million 2.1 million
Dec. 31, 2025 40.1 million - 1.7 million
Sept. 30, 2025 38.0 million - 1.8 million
June 30, 2025 44.8 million - 2.4 million

SCYX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 51.0 million
Dec. 31, 2025 43.5 million
Sept. 30, 2025 49.9 million
June 30, 2025 49.7 million

SCYX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 12.4 million 4.6 million -
Dec. 31, 2025 - 4.5 million 3.6 million -
Sept. 30, 2025 - 5.5 million 3.3 million -
June 30, 2025 - 7.1 million 3.8 million -

SCYX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 18.6 million -
Sept. 30, 2025 334000 -
June 30, 2025 1.4 million -

SCYX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SCYX

Price: $4.70

52 week price:
0.57
5.33

Payout Ratio Range:
-0.07%
1.10%

Earnings Per Share: -0.48 USD

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 45800

Ebitda: -8.0 million

Market Capitalization: 55.4 million

Links: